607 Results

People

  1. Shukla
    Shukla
  2. Steinherz
    Steinherz
  3. Trippett
    Trippett
  4. Kentsis
    Kentsis
  5. Forlenza
    Forlenza
  6. Ladanyi
    Ladanyi
  7. Sulis
    Sulis
  8. O'Reilly
    O'Reilly
  9. Cifani
    Cifani
  10. Kernan
    Kernan

Groups

  1. Hematologic Malignancies Service (607)
  2. Pediatrics, Department of (607)
  3. Center for Hematologic Malignancies (554)
  4. Pediatric Leukemia (455)
  5. GSK Faculty (220)
  6. Tow Center for Developmental Oncology (TCDO) (206)
  7. Sloan Kettering Institute Faculty (148)
  8. Department of Medicine (147)
  9. Hematologic Malignancies Research (114)
  10. Molecular Pharmacology and Chemistry Program Faculty (114)
  1. "Hematologic Malignancies Service"
Formats
  1. Journal Article (349)
  2. Meeting Abstract (232)
  3. Review (11)
  4. Research Letter (5)
  5. Editorial (4)
  6. Book Section (2)
  7. Conference Paper (2)
  8. Correspondence (1)
  9. Guidelines (1)
Groups
  1. Hematologic Malignancies Service (607)
  2. Pediatrics, Department of (607)
  3. Center for Hematologic Malignancies (554)
  4. Pediatric Leukemia (455)
  5. GSK Faculty (220)
  6. Tow Center for Developmental Oncology (TCDO) (206)

More Groups

People
  1. Peter Steinherz (221)
  2. Neerav Shukla (159)
  3. Tanya Trippett (126)
  4. Alex Kentsis (103)
  5. Christopher Forlenza (49)
  6. Marc Ladanyi (44)

More People

Years
  1. 2025 (11)
  2. 2024 (27)
  3. 2023 (37)
  4. 2022 (34)
  5. 2021 (29)
  6. 2020 (29)

More Years

Publications
  1. Blood (125)
  2. Journal of Clinical Oncology (61)
  3. Pediatric Blood and Cancer (57)
  4. Cancer Research (22)
  5. Cancer (18)
  6. Journal of Pediatric Hematology/Oncology (16)

More Publications

Publishers
  1. American Society of Hematology (134)
  2. American Society of Clinical Oncology (69)
  3. Wiley Periodicals, Inc (57)
  4. American Association for Cancer Research (56)
  5. Nature Publishing Group (39)
  6. Elsevier Inc. (33)

More Publishers

Results (607)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of 17-Allylamino-17-demethoxygeldanamycin (17AAG) in children with solid tumors
    Meeting Abstract

    Bagatell, R.; Gore, L.; Egorin, M.; Ho, R.; Boucher, N.; Heller, G.; Trippett, T.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia
    Journal Article

    Jeha, S.; Gaynon, P. S.; Razzouk, B. I.; Franklin, J.; Kadota, R.; Shen, V.; Litchtman-Jones, L.; Rytting, M.; Bomgaars, L. R.; Rheingold, S.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Clofarabine in paediatric patients with acute lymphoblastic leukaemia: Profile report
    Journal Article

    Steinherz, P. G.; Gandhi, V.
    Drugs and Therapy Perspectives (2006)

    Fulltext@MSK | Save
  • Non-Hodgkin's lymphoma in children and adolescents
    Journal Article

    Shukla, N. N.; Trippett, T. M.
    Current Oncology Reports (2006)

    Fulltext@MSK | Save
  • Pharmacokinetics of DX-8951 in pediatric cancer patients
    Meeting Abstract

    Trinh, M.; Colucci, P.; Kamida, M.; Danna, M.; De Jager, R.; Trippett, T.; Ducharme, M. P.
    Clinical Pharmacology & Therapeutics (2005)

    Fulltext@MSK | Save
  • Allogeneic or autologous stem cell transplantation (SCT) for the treatment of pediatric patients with non-Hodgkins lymphoma (NHL)
    Meeting Abstract

    Ricafort, R.; Trippett, T.; Kernan, N. A.; Small, T. N.; Prockop, S.; Scaradavou, A.; Keating, A.; O'Reilly, R. J.; Boulad, F.
    Blood (2005)

    Fulltext@MSK | Save
  • Phase II trials of clofarabine in pediatric acute leukemia
    Meeting Abstract

    Jeha, S.; Razzouk, B.; Gaynon, P.; Kadota, R.; Rheingold, S.; Luchtman-Jones, L.; Arceci, R.; Fernandez, M.; Weitman, S.; Steinherz, P.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Additive interaction between oxaliplatin and DMAG in pediatric acute lymphoblastic leukemia (ALL) cells. Evidence for interference with multiple signaling pathways
    Meeting Abstract

    Jayanthan, A.; Fowler, J.; Coppes, L.; Trippett, T.; Anderson, R.; Narendran, A.
    Blood (2005)

    Fulltext@MSK | Save
  • Cyclosporine, interferon-gamma, and interleukin-2 immunotherapy is tolerable and induces autoreactivity in patients with recurrent/refractory Hodgkin disease undergoing autologous stem cell transplantation with BEAM: A COG study
    Meeting Abstract

    Chen, A.; Hess, A.; Gardner, S.; Trippett, T.; de Alarcon, P.; Guillerman, R.; Hogan, S.; Mitchell, J.; Gamis, A.; Massey, V.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Expression profiling of-tyrosine kinase genes in synovial sarcoma reveals a highly distinct kinase repertoire and prominent overexpression of PDGFRA
    Meeting Abstract

    Barbashina, V.; Saito, T.; Shukla, N.; Chuai, S.; Olshen, A. B.; Antonescu, C. R.; Ladanyi, M.
    Modern Pathology (2005)

    Fulltext@MSK | Save